J0713 HCPCS Level II code: Injection, ceftazidime, per 500 mg
J0713 is the HCPCS code for “Injection, ceftazidime, per 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0713Injection, ceftazidime, per 500 mg
Short description: Inj ceftazidime per 500 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0713 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1996
Where J0713 sits
- 1J codesDrugs administered other than orally
- 2Active code J0713Injection, ceftazidime, per 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0713 mean?
J0713 is the HCPCS code for “Injection, ceftazidime, per 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0713?
CMS lists J0713’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0713
All J codesJ0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mgJ0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mgJ0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mgJ0706Injection, caffeine citrate, 5 mgJ0710Injection, cephapirin sodium, up to 1 gmJ0712Injection, ceftaroline fosamil, 10 mgJ0714Injection, ceftazidime and avibactam, 0.5 g/0.125 gJ0715Injection, ceftizoxime sodium, per 500 mgJ0716Injection, centruroides immune f(ab)2, up to 120 milligramsJ0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0720Injection, chloramphenicol sodium succinate, up to 1 gmJ0725Injection, chorionic gonadotropin, per 1,000 usp units